Document:

AMENDMENT

 

 

This first Amendment to the Exclusive License Agreement between
NORTH CAROLINA STATE UNIVERITY (“NCSU”) and 22nd CENTURY LIMITED, LLC (“LICENSEE”)
executed March 6, 2009 (the “Agreement”) is entered into on the 9th day of August 2012, (“Amendment Effective
Date”).

 

WHEREAS, on June 22nd, 2009 the Family Smoking Prevention and
Tobacco Control Act was enacted granting the U.S. Food and Drug Administration (“FDA”) regulatory control over all
tobacco products; and

 

WHEREAS, Licensee has initiated a program for commercial development
of a Licensed Product that is a Smoking Cessation Aid under Investigational New Drug application 103,589 filed with the FDA and
completed a 238 subject Phase II trial in 2012; and

 

WHEREAS, as of the Amendment Effective Date, Licensee’s
research, development and commercialization of Licensed Products, including that of its former sublicensee, have satisfied Licensee’s
due diligence obligations; and

 

WHEREAS NCSU and LICENSEE, (collectively “the Parties”)
wish to amend the Agreement; and

 

NOW THEREFORE, in consideration of the mutual covenants
set forth herein, the Parties hereby agree as follows:

 

		1.	The Agreement is amended as follows:

 

		(a)	Paragraph 1.03 of the Agreement is amended to read as follows:

 

		1.03	“Materials(s)” means Vector 21-41 seed covered by Plant Variety Protection Certificate No. 200100039 in the U.S.,
together with any progeny, mutants, derivatives, or replicated forms thereof, and all cells or plant tissues containing such material,
including any replicated and derivative forms thereof.

 

		(b)	The last sentence of Paragraph 4.01 is amended to read
as follows:

 

Variations from Appendix C must be expressly approved
by NCSU in writing, such approval not to be unreasonably withheld including that NCSU shall consider that factors causing such
delays may be regulatory in nature and may be beyond the control of the Licensee.

 

		(c)	The last two sentences of Paragraph 4.02 are amended
to read as follows:

 

Should Licensee anticipate not meeting any such
Development/Commercialization milestones, it may outline the reasons in writing to NCSU prior to the deadline and request a
reasonable extension of time or amendment of the milestone. NCSU shall reasonably consider any such request from
Licensee.

 

    	 

    	 

    
 

		(d)	The first sentence of Paragraph 10.01 of the Agreement is amended to read as follows:

 

10.01 – Term. This
Agreement shall become effective upon the Effective Date and, unless sooner terminated in accordance with any of the provisions
herein, shall remain in full force and effect until the date of expiration of the last to expire of the Patent Rights or the expiration
of Plant Variety Protection Certificate No. 200100039, whichever is later; provided however, that in those countries in which no
patent contained in the Patent Rights issues, this Agreement shall expire in such countries upon the earlier of (i) ten (10) years
after the first commercial sale of a Licensed Product or (ii) December 31, 2019 (the “Term”).

 

		(e)	Licensee’s address provided in Article 12 is amended
to read as follows:

 

22nd Century Limited, LLC

Attn: Joseph Pandolfino

9530 Main Street

Clarence, NY 14031

 

 

		(f)	The address provided in 12.03 is amended to read as follows:

 

22nd Century Limited, LLC

c/o Foley & Lardner LLP

3000 K Street, N.W., Sixth Floor

Washington, D.C. 20007

 

		(g)	Appendix A is amended to include the following Patent
Rights:

  

	MBSS
    Ref. No.	Country	Application
    Type	Application
    No.	Filing
    Date	Patent
    No.	Status	 
	 
	 	Israel	Foreign	 	 	159213	Granted	 
	5051.784.NZ	New Zealand	Foreign	 	 	530238	Granted	 
	5051.784.SG	Singapore	Foreign	2003073590	6/6/2002	P-101253	Granted	 
	5051.784.ZA	South Africa	Foreign	200400084	6/6/2002	200400084	Granted	 
	5051.784.TW	Taiwan	Foreign	 	 	I-256340	Granted	 
	5051.784	United States	Foreign	10/729121	12/5/2002	6907887	Granted	 

 

    	 

    	 

    
 

		(h)	The three milestones of Appendix C are amended to read
as follows:

 

December 31, 2013 – Licensee will have initiated
a phase III clinical trial for a Licensed Product that is a Smoking Cessation Aid.

 

December 31, 2014 – Licensee will have applied
for FDA approval for sale of a Licensed Product that is a Smoking Cessation Aid.

 

December 31, 2015 – Licensee will have completed
first commercial sale of Licensed Product that is a Smoking Cessation Aid.

 

		(g)	Appendix D is amended to read as follows:

 

 

APPENDIX D

ROYALTY REPORT FORM

 

22nd Century Limited, LLC Agreement Royalty Report for the Period
____________through___________.

 

Instructions: Please fill in all boxes (write "none"
if not applicable), and sign and date at bottom.

 

Prod.#_________ Prod. Name: ___________________

NCSU Patents: ___________________

Please provide patent numbers and patent
application numbers of all NCSU patents related to this product.

Government Approvals: ___________________

Date of First Commercial Sale: ___________________

 

	Country	Gross Billings	Deductions	Type of Deduction	Net Sales	Royalty Rate	Royalties Due
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	Subtotal for Product	 

 

Prod.#_________ Prod. Name: ___________________

NCSU Patents: ___________________

Please provide patent numbers and patent
application numbers of all NCSU patents related to this product.

Government Approvals: ___________________

Date of First Commercial Sale: ___________________

 

	Country	Gross Billings	Deductions	Type of Deduction	Net Sales	Royalty Rate	Royalties Due
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	Subtotal for Product	 

 

USE ADDITIONAL SHEETS FOR ADDITIONAL PRODUCTS.

 

Total amount enclosed $_______________

 

22nd Century Limited, LLC

By:Date:

 

Name and Title: ________________________________

 

    	 

    	 

    
 

		2.	All terms and conditions of the Agreement not specifically modified by this Amendment remain in full force and effect.

 

 

IN WITNESS WHEREOF, the Parties hereto have executed
this Amendment on the dates set forth below.

 

	NORTH CAROLINA STATE UNIVERSITY	22nd CENTURY LIMITED, LLC
	 	 
	 	 
	/s/ Billy B. Houghteling	/s/ Joseph Pandolfino
	Billy B. Houghteling	Joseph Pandolfino
	Executive Director	Chief Executive Officer
	 	 
	Date:  August 9, 2012	Date:  August 14, 2012SUBSCRIPTION AGREEMENT

 

SUBSCRIPTION AGREEMENT
(this “Agreement”) made as of the last date set forth on the signature page hereof between InvestView Inc. (the “Company”),
and the undersigned (the “Subscriber”).

 

WITNESSETH:

 

WHEREAS, the Company
is offering a maximum of two Units ($200,000) (the “Offering”) on a best efforts basis, at a price of $100,000 per
Unit. Each Unit consisting of (i) a $100,000 8% secured convertible promissory note of the Company, convertible into common stock,
$.001 per value per share (the “Common Stock”), at $4.00 per share into 25,000 shares of the Company’s Common
Stock, in the form attached hereto (the “Notes”), and (ii) common stock purchase warrants (the “Warrants”)
to purchase 12,500 of the shares of Common Stock at an exercise price of $6.00 per share. The Common Stock , Notes, the Warrants,
and the “Units” are hereinafter occasionally referred to as the Securities;

 

WHEREAS, the Company,
in its sole discretion, may exercise an over-allotment option for an additional Units up to $500,000;

 

WHEREAS, the Company
intends to offer the Units directly and, may, in its sole discretion, offer a portion of the units through placement agents; and

 

WHEREAS, the Subscriber
desires to purchase that number of Units set forth on the signature page hereof on the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration
of the premises and the mutual representations and covenants hereinafter set forth, the parties hereto do hereby agree as follows:

 

		I.	SUBSCRIPTION
                                                                                                          FOR UNITS AND REPRESENTATIONS
                                                                                                          BY SUBSCRIBER

 

1.1           The
Subscriber hereby irrevocably subscribes for and agrees to purchase from the Company such number of Units, and the Company agrees
to sell to the Subscriber as is set forth on the signature page hereof, at a per Unit price equal to $100,000 per Unit. The purchase
price is payable by personal or business check or money order made payable to “Investview Inc.” contemporaneously
with the execution and delivery of this Agreement by the Subscriber. Subscribers may also pay the subscription amount by, wire
transfer of immediately available funds to:

 

	 	Name:	INVESTVIEW INC.
	 	Bank:	J P Morgan Chase Bank, N.A.
	 	Account:	764233482
	 	ABA #:	021000021
	 	Address;	New York, New York, 10017

 

    	 

    	 

    

 

The Subscriber recognizes that the purchase of the Units involves
a high degree of risk including, but not limited to, the following: (a) the Company remains a development stage business with
limited operating history and requires substantial funds in addition to the proceeds of the Offering; (b) an investment in the
Company is highly speculative, and only investors who can afford the loss of their entire investment should consider investing
in the Company and the Units; (c) the Subscriber may not be able to liquidate its investment; (d) transferability of the Units,
including the Common Stock and Notes contained therein and Common Stock issuable upon exercise of the Notes (defined below) (sometimes
hereinafter collectively referred to as the “Securities”) is extremely limited; (e) in the event of a disposition,
the Subscriber could sustain the loss of its entire investment; (f) the Company has not paid any dividends since its inception
and does not anticipate paying any dividends; and (g) the Company may issue additional securities in the future which have rights
and preferences that are senior to those of the Common Stock.

 

1.2           The
Subscriber represents that the Subscriber is an “accredited investor” as such term is defined in Rule 501 of Regulation
D (“Regulation D”) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), as
indicated by the Subscriber’s responses to the questions contained in Article VII hereof, and that the Subscriber is able
to bear the economic risk of an investment in the Units.

 

1.3           The
Subscriber hereby acknowledges and represents that (a) the Subscriber has knowledge and experience in business and financial matters,
prior investment experience, including investment in securities that are non-listed, unregistered and/or not traded on a national
securities exchange nor on the Financial Industry Regulatory Authority (the “FINRA”) automated quotation system (“NASDAQ”),
or the Subscriber has employed the services of a “purchaser representative” (as defined in Rule 501 of Regulation
D), attorney and/or accountant to read all of the documents furnished or made available by the Company both to the Subscriber
and to all other prospective investors in the Units to evaluate the merits and risks of such an investment on the Subscriber’s
behalf; (b) the Subscriber recognizes the highly speculative nature of this investment; and (c) the Subscriber is able to bear
the economic risk that the Subscriber hereby assumes.

 

1.4           The
Subscriber hereby acknowledges receipt and careful review of this Agreement, the 34 Act Reports (as defined herein), including
all exhibits thereto and the Risk Factors contained therein, and any documents which may have been made available upon request
as reflected therein (collectively referred to as the “Offering Materials”) and hereby represents that the Subscriber
has been furnished by the Company during the course of the Offering with all information regarding the Company, the terms and
conditions of the Offering and any additional information that the Subscriber has requested or desired to know, and has been afforded
the opportunity to ask questions of and receive answers from duly authorized officers or other representatives of the Company
concerning the Company and the terms and conditions of the Offering.

 

1.5           (a)          In
making the decision to invest in the Units the Subscriber has relied solely upon the information provided by the Company in the
Offering Materials. To the extent necessary, the Subscriber has retained, at its own expense, and relied upon appropriate professional
advice regarding the investment, tax and legal merits and consequences of this Agreement and the purchase of the Units hereunder.
The Subscriber disclaims reliance on any statements made or information provided by any person or entity in the course of Subscriber’s
consideration of an investment in the Units other than the Offering Materials.

 

    	2

    	 

    

 

(b)          The
Subscriber represents that (i) the Subscriber was contacted regarding the sale of the Units by the Company (or an authorized agent
or representative thereof) with whom the Subscriber had a prior substantial pre-existing relationship and (ii) no Units were offered
or sold to it by means of any form of general solicitation or general advertising, and in connection therewith, the Subscriber
did not (A) receive or review any advertisement, article, notice or other communication published in a newspaper or magazine or
similar media or broadcast over television or radio, whether closed circuit, or generally available; or (B) attend any seminar
meeting or industry investor conference whose attendees were invited by any general solicitation or general advertising.

 

1.6           The
Subscriber hereby represents that the Subscriber, either by reason of the Subscriber’s business or financial experience
or the business or financial experience of the Subscriber’s professional advisors (who are unaffiliated with and not compensated
by the Company or any affiliate or selling agent of the Company, directly or indirectly), has the capacity to protect the Subscriber’s
own interests in connection with the transaction contemplated hereby.

 

1.7           The
Subscriber hereby acknowledges that the Offering has not been reviewed by the United States Securities and Exchange Commission
(the “SEC”) nor any state regulatory authority since the Offering is intended to be exempt from the registration requirements
of Section 5 of the Securities Act pursuant to Regulation D promulgated thereunder. The Subscriber understands that the Securities
have not been registered under the Securities Act or under any state securities or “blue sky” laws and agrees not
to sell, pledge, assign or otherwise transfer or dispose of the Securities unless they are registered under the Securities Act
and under any applicable state securities or “blue sky” laws or unless an exemption from such registration is available.

 

1.8           The
Subscriber understands that the Securities comprising the Units have not been registered under the Securities Act by reason of
a claimed exemption under the provisions of the Securities Act that depends, in part, upon the Subscriber’s investment intention.
In this connection, the Subscriber hereby represents that the Subscriber is purchasing the Securities for the Subscriber’s
own account for investment and not with a view toward the resale or distribution to others. The Subscriber, if an entity, further
represents that it was not formed for the purpose of purchasing the Securities.

 

1.9           The
Subscriber understands that there is a limited public market for the Common Stock issuable upon conversion of the Notes. The Subscriber
understands that even if more significant public market develops for such Securities, Rule 144 (“Rule 144”) promulgated
under the Securities Act requires for non-affiliates, among other conditions, a six month holding period prior to the resale (in
limited amounts) of securities acquired in a non-public offering without having to satisfy the registration requirements under
the Securities Act. The Subscriber understands and hereby acknowledges that the Company is under no obligation to register any
of the Securities under the Securities Act or any state securities or “blue sky” laws other than as set forth in Article
V.

 

1.10         The
Subscriber consents to the placement of a legend on any certificate or other document evidencing the Securities that such Securities
have not been registered under the Securities Act or any state securities or “blue sky” laws and setting forth or
referring to the restrictions on transferability and sale thereof contained in this Agreement. The Subscriber is aware that the
Company will make a notation in its appropriate records with respect to the restrictions on the transferability of such Securities.
The legend to be placed on each certificate shall be in form substantially similar to the following:

 

    	3

    	 

    

 

“THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE
SECURITIES OR “BLUE SKY LAWS,” AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED ABSENT
AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY
HAS RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

1.11         The
Subscriber understands that the Company will review this Agreement and is hereby given authority by the Subscriber to call Subscriber’s
bank or place of employment or otherwise review the financial standing of the Subscriber; and it is further agreed that the Company,
at its sole discretion, reserves the unrestricted right, without further documentation or agreement on the part of the Subscriber,
to reject or limit any subscription, to accept subscriptions for fractional Units and to close the Offering to the Subscriber
at any time and that the Company will issue stop transfer instructions to its transfer agent with respect to such Securities.

 

1.12         The
Subscriber hereby represents that the address of the Subscriber furnished by Subscriber on the signature page hereof is the Subscriber’s
principal residence if Subscriber is an individual or its principal business address if it is a corporation or other entity.

 

1.13         The
Subscriber represents that the Subscriber has full power and authority (corporate, statutory and otherwise) to execute and deliver
this Agreement and to purchase the Units. This Agreement constitutes the legal, valid and binding obligation of the Subscriber,
enforceable against the Subscriber in accordance with its terms.

 

1.14         If
the Subscriber is a corporation, partnership, limited liability company, trust, employee benefit plan, individual retirement account,
Keogh Plan, or other tax-exempt entity, it is authorized and qualified to invest in the Company and the person signing this Agreement
on behalf of such entity has been duly authorized by such entity to do so.

 

1.15         The
Subscriber acknowledges that if he or she is a Registered Representative of an FINRA member firm, he or she must give such firm
the notice required by the FINRA’s Rules of Fair Practice, receipt of which must be acknowledged by such firm in Section
7.3 below.

 

1.16         The
Subscriber acknowledges that at such time, if ever, as the Securities are registered (as such term is defined in Article V hereof),
sales of the Securities will be subject to state securities laws.

 

1.17         The
Subscriber represents that the Subscriber has read and fully understands the risks associated with the Company and the Units.

 

1.18         (a)          The
Subscriber agrees not to issue any public statement with respect to the Subscriber’s investment or proposed investment in
the Company or the terms of any agreement or covenant between them and the Company without the Company’s prior written consent,
except such disclosures as may be required under applicable law or under any applicable order, rule or regulation.

 

    	4

    	 

    

 

(b)          The
Company agrees not to disclose the names, addresses or any other information about the Subscribers, except as required by law.

 

1.19         The
Subscriber agrees to hold the Company and its directors, officers, employees, affiliates, controlling persons and agents and their
respective heirs, representatives, successors and assigns harmless and to indemnify them against all liabilities, costs and expenses
incurred by them as a result of (a) any sale or distribution of the Securities by the Subscriber in violation of the Securities
Act or any applicable state securities or “blue sky” laws; or (b) any false representation or warranty or any breach
or failure by the Subscriber to comply with any covenant made by the Subscriber in this Agreement (including the Confidential
Investor Questionnaire contained in Article VII herein) or any other document furnished by the Subscriber to any of the foregoing
in connection with this transaction.

 

1.20         The
Subscriber represents that neither the Subscriber or any affiliates of the Subscriber has an open short position in the common
stock of the Company and the Subscriber agrees that, so long as any of the Securities remain outstanding the Subscriber will not
enter into or effect any “short sales” (as such term is defined in Rule 3b-3 of the 1934 Act) of the Common Stock,
or shares of common stock issuable upon conversion of the Notes, or hedging transaction which establishes a net short position
with respect to the Common Stock or shares of common stock issuable upon conversion of the Notes.

 

		II.	REPRESENTATIONS
                                                                                                           BY AND COVENANTS OF
                                                                                                           THE COMPANY

 

The Company hereby represents
and warrants to the Subscriber that:

 

2.1           Organization,
Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under
the laws of the State of Nevada and has full corporate power and authority to conduct its business.

 

2.2           Capitalization
and Voting Rights. The authorized capital stock of the Company consists of 7,500,000 shares of Common Stock of which 4,550,733
shares are presently issued and outstanding, and 10,000,000 shares of preferred stock of which none are issued or outstanding.
All issued and outstanding shares of the Company are validly issued, fully paid and non-assessable. Except as set forth in the
Offering Materials and the 34 Act Reports, there are no outstanding options, warrants, agreements, convertible securities, preemptive
rights or other rights to subscribe for or to purchase any shares of capital stock of the Company. Except as set forth in the
Offering Materials and the 34 Act reports, and as otherwise required by law, there are no restrictions upon the voting or transfer
of any of the shares of capital stock of the Company pursuant to the Company’s Articles of Incorporation (the “Articles
of Incorporation”), By-Laws or other governing documents or any agreement or other instruments to which the Company is a
party or by which the Company is bound.

 

    	5

    	 

    

 

2.3           Authorization;
Enforceability. The Company has all corporate right, power and authority to enter into this Agreement and to consummate the
transactions contemplated hereby. All corporate action on the part of the Company, its directors and stockholders necessary for
the (i) authorization execution, delivery and performance of this Agreement by the Company; and (ii) authorization, sale, issuance
and delivery of the Securities contemplated hereby and the performance of the Company’s obligations hereunder has been taken.
This Agreement has been duly executed and delivered by the Company and constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, subject to laws of general application relating to bankruptcy,
insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies,
and to limitations of public policy. The Common Stock, when issued and fully paid for in accordance with the terms of this Agreement,
will be validly issued, fully paid and non-assessable. The issuance and sale of the Common Stock contemplated hereby will not
give rise to any preemptive rights or rights of first refusal on behalf of any person which have not been waived in connection
with this offering.

 

2.4           No
Conflict; Governmental Consents.

 

(a)          The
execution and delivery by the Company of this Agreement and the consummation of the transactions contemplated hereby will not
result in the violation of any material law, statute, rule, regulation, order, writ, injunction, judgment or decree of any court
or governmental authority to or by which the Company is bound, or of any provision of the Articles of Incorporation or By-Laws
of the Company, and will not conflict with, or result in a material breach or violation of, any of the terms or provisions of,
or constitute (with due notice or lapse of time or both) a default under, any lease, loan agreement, mortgage, security agreement,
trust indenture or other agreement or instrument to which the Company is a party or by which it is bound or to which any of its
properties or assets is subject, nor result in the creation or imposition of any lien upon any of the properties or assets of
the Company.

 

(b)          No
consent, approval, authorization or other order of any governmental authority is required to be obtained by the Company in connection
with the authorization, execution and delivery of this Agreement or with the authorization, issue and sale of the Units, except
such filings as may be required to be made with the SEC, FINRA, NASDAQ and with any state or foreign blue sky or securities regulatory
authority.

 

2.5           Licenses.
Except as otherwise set forth in the 34 Act Reports, the Company has sufficient licenses, permits and other governmental authorizations
currently required for the conduct of its business or ownership of properties and is in all material respects in compliance therewith.

 

2.6           Litigation.
The Company knows of no pending or threatened legal or governmental proceedings against the Company which could materially adversely
affect the business, property, financial condition or operations of the Company or which materially and adversely questions the
validity of this Agreement or any agreements related to the transactions contemplated hereby or the right of the Company to enter
into any of such agreements, or to consummate the transactions contemplated hereby or thereby. The Company is not a party or subject
to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality which
could materially adversely affect the business, property, financial condition or operations of the Company. There is no action,
suit, proceeding or investigation by the Company currently pending in any court or before any arbitrator or that the Company intends
to initiate.

 

2.7           Disclosure.
The information set forth in the Offering Materials as of the date hereof contains no untrue statement of a material fact nor
omits to state a material fact necessary in order to make the statements contained therein, in light of the circumstances under
which they were made, not misleading.

 

    	6

    	 

    

 

2.8           Investment
Company. The Company is not an “investment company” within the meaning of such term under the Investment Company
Act of 1940, as amended, and the rules and regulations of the SEC thereunder.

 

2.9           Placement
Agent. The Company, in its sole option, may engage, a placement agent to act as agent of the Company in connection with the
transactions contemplated by this Agreement.

 

2.10         Intellectual
Property.

 

(i)          To
the best of its knowledge, the Company owns or possesses sufficient legal rights to all patents, trademarks, service marks, trade
names, copyrights, trade secrets, licenses, information and other proprietary rights and processes necessary for its business
as now conducted and as presently proposed to be conducted, without any known infringement of the rights of others. Except as
disclosed in the 34 Act Reports, there are no material outstanding options, licenses or agreements of any kind relating to the
foregoing proprietary rights, nor is the Company bound by or a party to any material options, licenses or agreements of any kind
with respect to the patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information and other
proprietary rights and processes of any other person or entity other than such licenses or agreements arising from the purchase
of “off the shelf” or standard products. The Company has not received any written communications alleging that the
Company has violated or, by conducting its business as presently proposed to be conducted, would violate any of the patents, trademarks,
service marks, trade names, copyrights or trade secrets or other proprietary rights of any other person or entity.

 

(ii)         Except
as disclosed in the 34 Act Reports, the Company is not aware that any of its employees is obligated under any contract (including
licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court
or administrative agency, that would interfere with their duties to the Company or that would conflict with the Company’s
business as presently conducted.

 

(iii)        Neither
the execution nor delivery of this Agreement, nor the carrying on of the Company’s business by the employees of the Company,
nor the conduct of the Company’s business as presently conducted, will, to the best of the Company’s knowledge, conflict
with or result in a breach of the terms, conditions or provisions of, or constitute a default under, any contract, covenant or
instrument under which any employee is now obligated.

 

(iv)        To
the best of the Company’s knowledge, no employee of the Company, nor any consultant with whom the Company has contracted,
is in material violation of any term of any employment contract, proprietary information agreement or any other agreement relating
to the right of any such individual to be employed by, or to contract with, the Company because of the nature of the business
conducted by the Company; and to the best of the Company’s knowledge the continued employment by the Company of its present
employees, and the performance of the Company’s contracts with its independent contractors, will not result in any such
material violation. The Company has not received any written notice alleging that any such material violation has occurred. Except
as described in the 34 Act Reports, no employee of the Company has been granted the right to continued employment by the Company
or to any compensation following termination of employment with the Company except for any of the same which would not have a
material adverse effect on the business of the Company.

 

    	7

    	 

    

 

2.11         Title
to Properties and Assets; Liens, Etc. The Company has good and marketable title to its properties and assets, including the
properties and assets reflected in the most recent balance sheet included in the Financial Statements, and good title to its leasehold
estates, in each case subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than (a) those resulting from
taxes which have not yet become delinquent; (b) liens and encumbrances which do not materially detract from the value of the property
subject thereto or materially impair the operations of the Company; and (c) those that have otherwise arisen in the ordinary course
of business. The Company is in compliance with all material terms of each lease to which it is a party or is otherwise bound.

 

2.12         Obligations
to Related Parties. Except as described in the 34 Act Reports, there are no obligations of the Company to officers, directors,
stockholders, or employees of the Company other than (a) for payment of salary or other compensation for services rendered, (b)
reimbursement for reasonable expenses incurred on behalf of the Company and (c) for other standard employee benefits made generally
available to all employees (including stock option agreements outstanding under any stock option plan approved by the Board of
Directors of the Company). Except as may be disclosed in the 34 Act Reports, the Company is not a guarantor or indemnitor of any
indebtedness of any other person, firm or corporation.

 

2.13         34
Act Reports. The Company has provided the Subscriber with its Annual Report on Form 10-K for the year ended March 31, 2012
and its Form 10-Q for each of the quarter ended June 30, 2012 (the “34 Act Reports”). No statement of fact made by
the Company in its 34 Act Reports contains any untrue statement of a material fact or omits to state any material fact necessary
to make the statements contained therein not misleading in light of the circumstances under which such statements were made.

 

		III.	TERMS
                                                                                                            OF SUBSCRIPTION

 

3.1           Notes
and Warrants purchased by the Subscriber pursuant to this Agreement will be prepared for delivery to the Subscriber within 15
business days following the Closing at which such purchase takes place. The Subscriber hereby authorizes and directs the Company
to deliver the Notes and Warrants purchased by the Subscriber pursuant to this Agreement directly to the Subscriber’s residential
or business address indicated on the signature page hereto.

 

		IV.	CONDITIONS
                                                                                                           TO OBLIGATIONS OF THE
                                                                                                           SUBSCRIBERS

 

4.1           The
Subscriber’s obligation to purchase the Units at the Closing at which such purchase is to be consummated is subject to the
fulfillment on or prior to such Closing of the following conditions, which conditions may be waived at the option of each Subscriber
to the extent permitted by law:

 

(a)          Covenants.
All covenants, agreements and conditions contained in this Agreement to be performed by the Company on or prior to the date of
such Closing shall have been performed or complied with in all material respects.

 

    	8

    	 

    

 

(b)          No
Legal Order Pending. There shall not then be in effect any legal or other order enjoining or restraining the transactions
contemplated by this Agreement.

 

(c)          No
Law Prohibiting or Restricting Such Sale. There shall not be in effect any law, rule or regulation prohibiting or restricting
such sale or requiring any consent or approval of any person, which shall not have been obtained, to issue the Securities (except
as otherwise provided in this Agreement).

 

		V.	INTENTIONALLY
                                                                                                          LEFT BLANK

 

		VI.	MISCELLANEOUS

 

6.1           Any
notice or other communication given hereunder shall be deemed sufficient if in writing and sent by registered or certified mail,
return receipt requested, or delivered by hand against written receipt therefore, addressed as follows:

 

if to the
Company, to it at:

 

Investview Inc.

12244 South Business Park Drive, Suite 240

Draper, Utah 84020

Attn: John R. MacDonald, CFO

 

With a copy to:

 

Fleming PLLC

49 Front Street, Ste. 206

Rockville Center, New York
11570

Attn: Stephen M. Fleming, Esq.

 

if to the Subscriber, to the Subscriber’s
address indicated on the signature page of this Agreement.

 

Notices shall be deemed to have been given
or delivered on the date of mailing, except notices of change of address, which shall be deemed to have been given or delivered
when received.

 

6.2           Except
as otherwise provided herein, this Agreement shall not be changed, modified or amended except by a writing signed by the parties
to be charged, and this Agreement may not be discharged except by performance in accordance with its terms or by a writing signed
by the party to be charged.

 

6.3           This
Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives,
successors and assigns. This Agreement sets forth the entire agreement and understanding between the parties as to the subject
matter hereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them.

 

    	9

    	 

    

 

6.4           Upon
the execution and delivery of this Agreement by the Subscriber, this Agreement shall become a binding obligation of the Subscriber
with respect to the purchase of Units as herein provided, subject, however, to the right hereby reserved by the Company to enter
into the same agreements with other subscribers and to add and/or delete other persons as subscribers.

 

6.5           NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT ALL THE TERMS AND
PROVISIONS HEREOF SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO SUCH
STATE’S PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT A JUDICIAL PROCEEDING IS NECESSARY, THE SOLE FORUM FOR RESOLVING
DISPUTES ARISING OUT OF OR RELATING TO THIS AGREEMENT IS THE SUPREME COURT OF THE STATE OF NEW YORK IN AND FOR THE COUNTY OF NEW
YORK OR THE FEDERAL COURTS FOR SUCH STATE AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY IRREVOCABLY CONSENT
TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.

 

6.6           In
order to discourage frivolous claims the parties agree that unless a claimant in any proceeding arising out of this Agreement
succeeds in establishing his claim and recovering a judgment against another party (regardless of whether such claimant succeeds
against one of the other parties to the action), then the other party shall be entitled to recover from such claimant all of its/their
reasonable legal costs and expenses relating to such proceeding and/or incurred in preparation therefor.

 

6.7           The
holding of any provision of this Agreement to be invalid or unenforceable by a court of competent jurisdiction shall not affect
any other provision of this Agreement, which shall remain in full force and effect. If any provision of this Agreement shall be
declared by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced in whole or in part, such
provision shall be interpreted so as to remain enforceable to the maximum extent permissible consistent with applicable law and
the remaining conditions and provisions or portions thereof shall nevertheless remain in full force and effect and enforceable
to the extent they are valid, legal and enforceable, and no provisions shall be deemed dependent upon any other covenant or provision
unless so expressed herein.

 

6.8           It
is agreed that a waiver by either party of a breach of any provision of this Agreement shall not operate, or be construed, as
a waiver of any subsequent breach by that same party.

 

6.9           The
parties agree to execute and deliver all such further documents, agreements and instruments and take such other and further action
as may be necessary or appropriate to carry out the purposes and intent of this Agreement.

 

6.10         This
Agreement may be executed in two or more counterparts each of which shall be deemed an original, but all of which shall together
constitute one and the same instrument.

 

6.11         Nothing
in this Agreement shall create or be deemed to create any rights in any person or entity not a party to this Agreement, except
(a) for the holders of Registrable Securities.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	10

    	 

    

 

		VII.	CONFIDENTIAL
                                                                                                            INVESTOR QUESTIONNAIRE

 

7.1           The
Subscriber represents and warrants that he, she or it comes within one category marked below, and that for any category marked,
he, she or it has truthfully set forth, where applicable, the factual basis or reason the Subscriber comes within that category.
ALL INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL. The undersigned agrees to furnish any additional
information which the Company deems necessary in order to verify the answers set forth below.

 

		Category A       	The undersigned is an individual (not a partnership,
corporation, etc.) whose individual net worth, or joint net worth with his or her spouse, presently exceeds $1,000,000.

 

Explanation. In calculating
net worth you may include equity in personal property and real estate, including your principal residence, cash, short-term investments,
stock and securities. Equity in personal property and real estate should be based on the fair market value of such property less
debt secured by such property.

 

		Category  B        	The undersigned is an individual (not a partnership,
corporation, etc.) who had an income in excess of $200,000 in each of the two most recent years, or joint income with his or her
spouse in excess of $300,000 in each of those years (in each case including foreign income, tax exempt income and full amount
of capital gains and losses but excluding any income of other family members and any unrealized capital appreciation) and has
a reasonable expectation of reaching the same income level in the current year.

 

		Category C        	The undersigned is a director or executive officer of
the Company which is issuing and selling the Securities.

 

		Category D        	The undersigned is a bank; a savings and loan association;
insurance company; registered investment company; registered business development company; licensed small business investment
company (“SBIC”); or employee benefit plan within the meaning of Title 1 of ERISA and (a) the investment decision
is made by a plan fiduciary which is either a bank, savings and loan association, insurance company or registered investment advisor,
or (b) the plan has total assets in excess of $5,000,000 or (c) is a self directed plan with investment decisions made solely
by persons that are accredited investors. (describe entity)

 

	 
	 

 

		Category E        	The undersigned is a private business development company
as defined in section 202(a)(22) of the Investment Advisors Act of 1940. (describe entity)

 

	 
	 

 

		Category F        	The undersigned is either a corporation, partnership,
Massachusetts business trust, or non-profit organization within the meaning of Section 501(c)(3) of the Internal Revenue Code,
in each case not formed for the specific purpose of acquiring the Common Stock and with total assets in excess of $5,000,000.
(describe entity)

 

    	11

    	 

    

 

	 
	 

 

		Category G        	The undersigned is a trust with total assets in excess
of $5,000,000, not formed for the specific purpose of acquiring the Securities, where the purchase is directed by a “sophisticated
investor” as defined in Regulation 506(b)(2)(ii) under the Act.

 

		Category H        	The undersigned is an entity (other than a trust) in
which all of the equity owners are “accredited investors” within one or more of the above categories. If relying upon
this Category alone, each equity owner must complete a separate copy of this Agreement. (describe entity)

 

	 
	 

 

The undersigned agrees that
the undersigned will notify the Company at any time on or prior to the Closing Date in the event that the representations and
warranties in this Agreement shall cease to be true, accurate and complete.

 

		7.2	MANNER IN WHICH TITLE IS TO BE HELD. (circle one)

 

		(a)	Individual Ownership

		(b)	Community Property

		(c)	Joint Tenant with Right of Survivorship (both parties must
                                                               sign)

		(d)	Partnership*

		(e)	Tenants in Common

		(f)	Company*

		(g)	Trust*

		(h)	Other*

 

*If Securities are being
subscribed for by an entity, the attached Certificate of Signatory must also be completed.

 

    	12

    	 

    

 

FINRA AFFILIATION.

 

Are you affiliated or associated with
an FINRA member firm (please check one):

 

Yes _________               No __________

 

If Yes, please describe:

	 
	 
	 

 

*If Subscriber is a Registered Representative
with an FINRA member firm, have the following acknowledgment signed by the appropriate party:

 

The undersigned FINRA member firm acknowledges
receipt of the notice required by Article 3, Sections 28(a) and (b) of the Rules of Fair Practice.

 

	 	 
	Name of FINRA Member Firm	 
	 	 
	By:	 	 
	 	Authorized Officer	 
	 	 	 
	Date:	 	 

 

7.3           The
undersigned is informed of the significance to the Company of the foregoing representations and answers contained in the Confidential
Investor Questionnaire contained in this Article VII and such answers have been provided under the assumption that the Company
will rely on them.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK]

 

    	13

    	 

    

 

NUMBER OF UNITS            X $100,000  = _______________(the “Purchase Price”)

 

	 	 	 
	Signature	 	Signature (if purchasing jointly)
	 	 	 
	 	 	 
	Name Typed or Printed	 	Name Typed or Printed
	 	 	 
	 	 	 
	Title (if Subscriber is an Entity)	 	Title (if Subscriber is an Entity)
	 	 	 
	 	 	 
	Entity Name (if applicable)	 	Entity Name (if applicable
	 	 	 
	 	 	 
	 	 	 
	Address	 	Address
	 	 	 
	 	 	 
	City, State and Zip Code	 	City, State and Zip Code
	 	 	 
	 	 	 
	Telephone-Business	 	Telephone-Business
	 	 	 
	 	 	 
	Telephone-Residence	 	Telephone-Residence
	 	 	 
	 	 	 
	Facsimile-Business	 	Facsimile-Business
	 	 	 
	 	 	 
	Facsimile-Residence	 	Facsimile-Residence
	 	 	 
	 	 	 
	Tax ID # or Social Security #	 	Tax ID # or Social Security #
	 	 	 
	Name in which securities should be issued:	 	 

 

Dated:         _____________  , 2012

 

This Subscription
Agreement is agreed to and accepted as of August __, 2012.

 

	 	INVESTVIEW INC.
	 	 
	 	By:	 
	 	Name:  John R. MacDonald
	 	Title: Chief Financial Officer

 

    	14

    	 

    

 

CERTIFICATE OF SIGNATORY

 

(To be completed if Units are

being subscribed for by an entity)

 

I, ____________________________, am the
____________________________ of __________________________________________ (the “Entity”).

 

I certify that I am empowered and duly
authorized by the Entity to execute and carry out the terms of the Subscription Agreement and to purchase and hold the Securities,
and certify further that the Subscription Agreement has been duly and validly executed on behalf of the Entity and constitutes
a legal and binding obligation of the Entity.

 

IN WITNESS WHEREOF, I have set my hand
this ________ day of _________________, 2012

 

	 	 
	 	(Signature)

 

    	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}]]